Study compared use of chemotherapy and radiotherapy in 280,000 people from Britain, Australia, Norway and Canada ...

Lung Cancer is the most deadly cancer in the U.S. About 70% of people who develop lung cancer pass away within five years, ...

I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...

Julian McMahon, known for Nip/Tuck and Charmed, died at 56 from metastatic cancer. Co-stars Alyssa Milano and Ioan Gruffudd ...

Swedish Match, a subsidiary of Philip Morris International, makes the ZYN pouches. The FDA's authorization noted the pouches posed a lower risk of cancer and other serious health conditions because ...

A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 patients with small cell ...

ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

Julian McMahon, known for his roles in 'Nip/Tuck' and 'Charmed,' sadly passed away on July 2, 2025, at 56, due to ...

The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...

McDonald discusses her groundbreaking path in interventional pulmonology, overcoming barriers with early lung cancer ...

New research reveals critical gaps in treatment for advanced non–small cell lung cancer (NSCLC), emphasizing the need for ...

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.